Artelo Biosciences Announces New Data from an Initial Food Effect Investigation with ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain

Safety and Pharmacokinetic Data Support Dosing of
ART26.12 in Fed or Fasted Conditions

Completion of Positive Single Ascending Dose Study with a Preliminary Food Effect Assessment
Advances ART26.12 Toward Multiple Ascending Dose Trial

Read more at globenewswire.com